Fig. 8From: Cost-effectiveness of continuous glucose monitoring with FreeStyle Libre® in Brazilian insulin-treated patients with types 1 and 2 diabetes mellitusCost-effectiveness acceptability curve for FSL-plus-SMBG versus SMBG-only in T1DM. FSL, FreeStyle Libre; SMBG, self-monitoring of blood glucoseBack to article page